The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
The ugly truth about being beautiful
Cosmetic testing that uses animals is notably controversial. Dripping chemicals into the eyes, shaving the fur and deliberate irritation to skin, long exposure to potential carcinogens or dangerous substances without pain relief drugs…
Even if not tested, products often include substances like animal fat, fish scales, hormones, stomach enzymes, gelatin, liver oil, animal gland steroids, wax and honey or even shark and turtle oil.
The European Union took a step forward in March 2013, when a new law was fully implemented and made it illegal to sell animal-tested cosmetics in Europe, even if the testing was done outside Europe. However, vivisection (experimentation on live animals) continues. 1,170,326 signatures were collected, but the initiative to stop vivisection was denied by the EU Commission.
Despite the remarkable progress that’s been made, ingredients used in cosmetics may still be tested on animals in the EU under REACH, the world’s largest chemical testing programme. Also testing on animals for household products continues. And when you Google cosmetic companies that still test on animals, around 330 names come up!
Scientists should follow the three Rs in order to reduce the impact of research on animals: Reduction, Refinement and Replacement. Reducing the number of animals used in experiments and refining the experiment in a way that the animal suffers as little as possible should be commonplace when they can't abstain from the use of animals. But the third “R” is the best way to go – replacement with alternative methods such as in-vitro testing, research with human volunteers or test tube methods.
Products in Europe that are not tested on animals carry the symbol of the “Leaping Bunny”. Take action, look for information, sign petitions and check what products you are buying. #becrueltyfree
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.